Personalized Lifestyle Intervention and Weight Control
1 other identifier
interventional
53
1 country
1
Brief Summary
This trial aims to investigate whether tailored lifestyle consultation through SNP testing leads to more effective weight loss among overweight or obese individuals compared to general lifestyle guidance for weight control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2019
CompletedStudy Start
First participant enrolled
June 11, 2019
CompletedFirst Posted
Study publicly available on registry
September 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 2, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 2, 2020
CompletedResults Posted
Study results publicly available
October 6, 2025
CompletedJanuary 6, 2026
October 1, 2025
1.4 years
February 18, 2019
July 4, 2024
December 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Body Weight (kg)
Change was calculated as the value at the later time point minus the value at baseline (i.e., value at about 5 months after randomization minus baseline, and value at study completion (\~17 months) minus baseline). Positive values represent increases from baseline, and negative values represent decreases.
About 5 months after randomization and at study completion (~17 months)
Secondary Outcomes (3)
Body Fat Mass (kg)
About 5 months after randomization and at study completion (~17 months)
Body Fat Percentage (%)
About 5 months after randomization and at study completion (~17 months)
Skeletal Muscle Mass (kg)
About 5 months after randomization and at study completion (~17 months)
Study Arms (2)
Disclosure of obesity-related genetic risk with tailored lifestyle recommendations
EXPERIMENTALParticipants received their obesity-related genetic test results, including variants in FTO (rs9939609), MC4R (rs17782313), and BDNF (rs6265), along with genotype-tailored lifestyle recommendations. The counseling materials encouraged risk-allele carriers to adopt healthier behaviors such as reducing fat intake, limiting snacking, and avoiding emotional eating. Personalized genetic results and recommendations were delivered at baseline through a user-friendly report.
Disclosure of non-obesity-related genetic traits only
ACTIVE COMPARATORParticipants received genetic test results limited to non-obesity-related traits (e.g., beauty-related genes). They did not receive any obesity- or metabolism-related genetic information or tailored lifestyle recommendations. The full obesity-related genetic results were disclosed only after completion of the final follow-up.
Interventions
Provided only with genetic test results related to beauty traits at baseline; information on metabolic health-related SNPs was disclosed only after the final follow-up assessment.
They received their complete SNP results, including obesity-related traits, along with corresponding lifestyle recommendations.
Eligibility Criteria
You may qualify if:
- Korean adults aged 18 years and older who are interested in weight management through dietary and/or exercise therapy.
- Individuals who are able and willing to participate consistently for the entire 2-year study period.
You may not qualify if:
- Individuals with any illness requiring regular medical treatment in a hospital.
- Individuals currently taking long-term prescribed medications.
- Individuals diagnosed with eating disorders or mental illnesses (e.g., depression, panic disorder) by a physician.
- Individuals who have undergone gastric surgery for weight loss.
- Individuals who have undergone heart surgery or cancer surgery.
- Individuals with severe anemia.
- Individuals who are unable to engage in physical exercise.
- Pregnant or breastfeeding women, or those planning to become pregnant within 2 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NaNa Keumlead
- National Research Foundation of Koreacollaborator
- DongGuk Universitycollaborator
Study Sites (1)
Dongguk University
Goyang-si, Gyeonggi-do, 10326, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr.NaNa Keum
- Organization
- Dongguk University
Study Officials
- PRINCIPAL INVESTIGATOR
NaNa Keum, ScD
DongGuk University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This was an open-label randomized controlled trial; no masking was implemented for participants, investigators, or outcome assessors.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 18, 2019
First Posted
September 6, 2019
Study Start
June 11, 2019
Primary Completion
November 2, 2020
Study Completion
November 2, 2020
Last Updated
January 6, 2026
Results First Posted
October 6, 2025
Record last verified: 2025-10